Bogaert Anne-Marie, Hoorens Anne, Praet Marleen, Van Dorpe Jo, Poppe Bruce, De Scheerder Marie-Angélique
Department of Nephrology, AZ Sint-Elisabeth, Zottegem, Belgium.
Department of Pathology, Ghent University Hospital, Ghent, Belgium.
Clin Kidney J. 2019 Dec 10;14(1):429-431. doi: 10.1093/ckj/sfz165. eCollection 2021 Jan.
We describe the case of a woman with minimal glomerular changes on initial kidney biopsy. On long-term follow-up, the patient developed nephrotic proteinuria and a second kidney biopsy was performed, which revealed focal segmental glomerulosclerosis (FSGS). Findings from electron microscopy (EM) examination suggested a genetic form of FSGS. Next-generation sequencing showed heterozygosity for a mutation in . Collagen IV nephropathies can be linked to late-onset FSGS. By establishing a genetic cause of FSGS, immunosuppressive treatment can be avoided. This case emphasizes the importance of re-biopsy in cases of a non-explained rise in proteinuria. EM can be helpful in differentiating between primary and secondary FSGS and informing treatment strategies. In cases of adult-onset FSGS that cannot be categorized by clinical-pathological assessment, genetic testing should be considered.
我们描述了一名女性患者的病例,其初次肾活检显示肾小球改变轻微。在长期随访中,该患者出现肾病性蛋白尿,并进行了第二次肾活检,结果显示为局灶节段性肾小球硬化(FSGS)。电子显微镜(EM)检查结果提示为遗传性FSGS。二代测序显示存在某基因突变的杂合性。IV型胶原肾病可与迟发性FSGS相关。通过确定FSGS的遗传病因,可避免免疫抑制治疗。该病例强调了在蛋白尿不明原因升高的情况下再次活检的重要性。EM有助于区分原发性和继发性FSGS,并为治疗策略提供依据。在无法通过临床病理评估进行分类的成人发病FSGS病例中,应考虑进行基因检测。